Please use this identifier to cite or link to this item:
http://publications.jrc.ec.europa.eu/repository/handle/JRC30447
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | APOSTOLIDIS CHRISTOS | en_GB |
dc.contributor.author | MOLINET Roger | en_GB |
dc.contributor.author | MCGINLEY JOHN | en_GB |
dc.contributor.author | MOELLENBECK J. | en_GB |
dc.contributor.author | MORGENSTERN ALFRED | en_GB |
dc.contributor.author | ABBAS KAMEL | en_GB |
dc.date.accessioned | 2010-02-25T14:52:58Z | - |
dc.date.available | 2005-09-12 | en_GB |
dc.date.available | 2010-02-25T14:52:58Z | - |
dc.date.issued | 2005 | en_GB |
dc.date.submitted | 2005-09-07 | en_GB |
dc.identifier.citation | APPLIED RADIATION AND ISOTOPES vol. 62 p. 383-387 | en_GB |
dc.identifier.uri | http://publications.jrc.ec.europa.eu/repository/handle/JRC30447 | - |
dc.description.abstract | The feasibility of producing Ac-225 by proton irradiation of Ra-226 in a cyclotron through the reaction Ra-226(p,2n)Ac-225 has been experimentally demonstrated for the first time. Proton energies were varied from 8.8 to 24.8MeV and cross-sections were determined by radiochemical analysis of reaction yields. Maximum yields were reached at incident proton energies of 16.8 MeV. Radiochemical separation of Ac-225 from the irradiated target yielded a product suitable for targeted alpha therapy of cancer. | en_GB |
dc.description.sponsorship | JRC.E.5-Nuclear chemistry | en_GB |
dc.format.medium | Printed | en_GB |
dc.language | ENG | en_GB |
dc.publisher | Elsevier B.V. | en_GB |
dc.relation.ispartofseries | JRC30447 | en_GB |
dc.title | Cyclotron Production of Ac-225 for Targeted Alpha Therapy | en_GB |
dc.type | Articles in periodicals and books | en_GB |
JRC Directorate: | Nuclear Safety and Security |
Files in This Item:
There are no files associated with this item.
Items in repository are protected by copyright, with all rights reserved, unless otherwise indicated.